Article
Computational evaluation of Fenugreek-derived compounds as FGFR2 inhibitors for cancer therapy
2026-06-22
Abstract excerpt
<title>Abstract</title> <p> Fibroblast Growth Factor Receptor 2 (FGFR2) is an important target in cancer therapy, particularly breast cancer, where its overexpression is associated with disease progression and poor prognosis. Current treatments face limitations such as drug resistance and adverse side effects, underscoring the need for alternative therapeutic agents. This study investigated fenugreek-derived phy...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9a2581b0-3bb0-5410-a7db-39fd0d329796
- DOI
- 10.21203/rs.3.rs-9861980/v1
